Brief About Dr. Rakesh Jalali
Dr. Rakesh Jalali, a Radiation Oncologist based in Chennai, India, boasts an impressive 27 years of experience in the field. He has been recognized internationally for his expertise, winning the Top Radiation Oncologist Award for three consecutive years from 2014 to 2017. Dr. Jalali is known for establishing the TMH Neuro-Oncology group, considered the premier unit of its kind in India and renowned worldwide. He was honored with the Oncologist Award by Medscape in 2014.
Dr. Jalali completed his MBBS from Government Medical College, Jammu (University of Jammu, India) in 1990, followed by an MD in Radiation and Oncology in 1994 from PGIMER, Chandigarh, where he received the “Merit of First Order” award. He also served as a Senior Researcher at the Royal Marsden NHS Trust Academic Unit in London. Specializing in Radiation Therapy, Chemotherapy, solid cancers, Brachytherapy, Proton therapy, and Stereotactic radiosurgery, Dr. Jalali has made significant contributions to over 300 peer-reviewed publications at the international level. His research has been published in prestigious journals such as The Lancet, JAMA Oncology, Lancet Oncology, and JCO.
Dr. Jalali is an active member of various committees, including the Tata Memorial Hospital IRB, the American Society of Therapeutic Radiology & Oncology (ASTRO), the Association Of Radiation Oncologists of India (AROI), the Society of Neuro-oncology (USA), among others. His special interests lie in Radiation Therapy, Chemotherapy, solid cancers, Brachytherapy, Proton therapy, and Stereotactic radiosurgery.
